Please select the option that best describes you:

Would you consider adding gabapentin off label for use in the treatment of glioblastoma at this time?  

Based on recent retrospective research showing potential survival benefit in gliomas Bernstock et al., PMID 40374596



Answer from: Radiation Oncologist at Academic Institution
Comments
Radiation Oncologist at University of Arizona
Thanks, Dr. @Mehta, for so eloquently contextualiz...
Radiation Oncologist at Northeast Oklahoma Cancer Center
I'm not sure I understand why it should be costly ...
Radiation Oncologist at Florida International University
The conduct of a multi-center phase three randomiz...
Radiation Oncologist at NE Louisiana Cancer Institute
Could an organization like this help with funding?...
Sign in or Register to read more

Answer from: Radiation Oncologist at Academic Institution
Sign in or Register to read more

Answer from: Radiation Oncologist at Academic Institution
Comments
Radiation Oncologist at West Virginia University
A 4-month median OS benefit from gabapentin is bet...
Radiation Oncologist at Northeast Radiation Oncology
👏👏👏
Sign in or Register to read more

Answer from: at Academic Institution
Sign in or Register to read more